| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.09e-05 | 303 | 92 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA2 BCL9L NCOA3 ATN1 PPRC1 NACA BCL9 DHX9 NCOR1 SMARCC2 CNOT2 | 5.45e-05 | 562 | 92 | 11 | GO:0003712 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOA2 BCL9L NCOA3 SH3RF1 ATN1 PPRC1 NACA SH2D3C ICE1 BCL9 DHX9 NCOR1 ABI2 SMARCC2 CNOT2 GAB1 | 7.31e-05 | 1160 | 92 | 16 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOA2 BCL9L NCOA3 SH3RF1 ATN1 PPRC1 NACA SH2D3C ICE1 BCL9 TAB3 DHX9 NCOR1 ABI2 SMARCC2 CNOT2 GAB1 | 1.36e-04 | 1356 | 92 | 17 | GO:0060090 |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 5.11e-04 | 34 | 92 | 3 | GO:0046966 | |
| GeneOntologyMolecularFunction | transcription factor binding | NCOA2 NCOA3 PPRC1 NACA GATA1 DHX9 NCOR1 PER3 ZNF296 PTPRN CNOT2 | 6.80e-04 | 753 | 92 | 11 | GO:0008134 |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 7.67e-04 | 39 | 92 | 3 | GO:0000993 | |
| GeneOntologyBiologicalProcess | positive regulation of Arp2/3 complex-mediated actin nucleation | 4.58e-06 | 8 | 91 | 3 | GO:2000601 | |
| GeneOntologyBiologicalProcess | pancreatic D cell differentiation | 1.93e-05 | 2 | 91 | 2 | GO:0003311 | |
| GeneOntologyBiologicalProcess | positive regulation of actin nucleation | 2.92e-05 | 14 | 91 | 3 | GO:0051127 | |
| GeneOntologyBiologicalProcess | developmental growth | NCOA3 EPPK1 ATN1 FOSL2 NACA PUM2 TNS2 BCL9 NCOR1 SLC12A2 TMEM108 PAX7 WASF1 AGRN | 4.37e-05 | 911 | 91 | 14 | GO:0048589 |
| GeneOntologyBiologicalProcess | COPII-coated vesicle cargo loading | 6.46e-05 | 18 | 91 | 3 | GO:0090110 | |
| GeneOntologyBiologicalProcess | cellular response to Thyroglobulin triiodothyronine | 1.15e-04 | 4 | 91 | 2 | GO:1904017 | |
| GeneOntologyCellularComponent | SCAR complex | 1.71e-05 | 12 | 91 | 3 | GO:0031209 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 2.21e-05 | 13 | 91 | 3 | GO:1990907 | |
| GeneOntologyCellularComponent | COPII vesicle coat | 4.29e-05 | 16 | 91 | 3 | GO:0030127 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 8.10e-04 | 42 | 91 | 3 | GO:0070971 | |
| GeneOntologyCellularComponent | hemidesmosome | 1.00e-03 | 11 | 91 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.15e-03 | 269 | 91 | 6 | GO:0036464 | |
| GeneOntologyCellularComponent | transcription regulator complex | 1.15e-03 | 596 | 91 | 9 | GO:0005667 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.22e-03 | 272 | 91 | 6 | GO:0090575 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 1.60e-03 | 287 | 91 | 6 | GO:0035770 | |
| GeneOntologyCellularComponent | chromatin | NCOA2 NCOA3 TCF7 FOXN4 FOSL2 GATA1 RFX6 ICE1 ONECUT1 DHX9 NCOR1 TPRX1 SMARCC2 PAX7 FOXK1 | 1.74e-03 | 1480 | 91 | 15 | GO:0000785 |
| Domain | PAS | 1.71e-05 | 32 | 91 | 4 | SM00091 | |
| Domain | PAS | 2.19e-05 | 34 | 91 | 4 | IPR000014 | |
| Domain | PAS | 2.19e-05 | 34 | 91 | 4 | PS50112 | |
| Domain | BCL9_beta-catenin-bd_dom | 2.35e-05 | 2 | 91 | 2 | IPR024670 | |
| Domain | BCL9 | 2.35e-05 | 2 | 91 | 2 | PF11502 | |
| Domain | DUF4927 | 2.35e-05 | 2 | 91 | 2 | PF16279 | |
| Domain | DUF4927 | 2.35e-05 | 2 | 91 | 2 | IPR032565 | |
| Domain | Bcl-9 | 2.35e-05 | 2 | 91 | 2 | IPR015668 | |
| Domain | DUF1518 | 7.02e-05 | 3 | 91 | 2 | PF07469 | |
| Domain | DUF1518 | 7.02e-05 | 3 | 91 | 2 | IPR010011 | |
| Domain | Nuc_rcpt_coact_Ncoa-typ | 7.02e-05 | 3 | 91 | 2 | IPR014920 | |
| Domain | SRC-1 | 7.02e-05 | 3 | 91 | 2 | IPR014935 | |
| Domain | SCAR/WAVE_fam | 7.02e-05 | 3 | 91 | 2 | IPR028288 | |
| Domain | Src1_rcpt_coact | 7.02e-05 | 3 | 91 | 2 | IPR008955 | |
| Domain | Nuclear_rcpt_coactivator | 7.02e-05 | 3 | 91 | 2 | IPR017426 | |
| Domain | DUF1518 | 7.02e-05 | 3 | 91 | 2 | SM01151 | |
| Domain | SRC-1 | 7.02e-05 | 3 | 91 | 2 | PF08832 | |
| Domain | - | 7.02e-05 | 3 | 91 | 2 | 4.10.630.10 | |
| Domain | Nuc_rec_co-act | 7.02e-05 | 3 | 91 | 2 | PF08815 | |
| Domain | DUF1908 | 1.40e-04 | 4 | 91 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 1.40e-04 | 4 | 91 | 2 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 1.40e-04 | 4 | 91 | 2 | IPR023142 | |
| Domain | - | 1.40e-04 | 4 | 91 | 2 | 1.20.1480.20 | |
| Domain | PAS | 2.38e-04 | 25 | 91 | 3 | PF00989 | |
| Domain | PAS_fold | 2.38e-04 | 25 | 91 | 3 | IPR013767 | |
| Domain | PAC | 2.68e-04 | 26 | 91 | 3 | IPR001610 | |
| Domain | PAC | 2.68e-04 | 26 | 91 | 3 | SM00086 | |
| Domain | Sec23/24_helical_dom | 3.48e-04 | 6 | 91 | 2 | IPR006900 | |
| Domain | Nuc_rcpt_coact | 3.48e-04 | 6 | 91 | 2 | IPR009110 | |
| Domain | Sec23_24_beta_S | 3.48e-04 | 6 | 91 | 2 | IPR012990 | |
| Domain | zf-Sec23_Sec24 | 3.48e-04 | 6 | 91 | 2 | PF04810 | |
| Domain | Sec23_trunk | 3.48e-04 | 6 | 91 | 2 | PF04811 | |
| Domain | Sec23_helical | 3.48e-04 | 6 | 91 | 2 | PF04815 | |
| Domain | Sec23_BS | 3.48e-04 | 6 | 91 | 2 | PF08033 | |
| Domain | Sec23/24_trunk_dom | 3.48e-04 | 6 | 91 | 2 | IPR006896 | |
| Domain | Znf_Sec23_Sec24 | 3.48e-04 | 6 | 91 | 2 | IPR006895 | |
| Domain | - | 4.68e-04 | 74 | 91 | 4 | 3.40.50.410 | |
| Domain | VWF_A | 1.39e-03 | 99 | 91 | 4 | IPR002035 | |
| Domain | Gelsolin | 2.06e-03 | 14 | 91 | 2 | PF00626 | |
| Domain | Gelsolin-like_dom | 2.06e-03 | 14 | 91 | 2 | IPR007123 | |
| Domain | WH2 | 2.06e-03 | 14 | 91 | 2 | SM00246 | |
| Domain | WH2 | 2.70e-03 | 16 | 91 | 2 | PF02205 | |
| Domain | - | 4.27e-03 | 218 | 91 | 5 | 1.10.10.10 | |
| Domain | WH2_dom | 4.64e-03 | 21 | 91 | 2 | IPR003124 | |
| Pathway | BIOCARTA_ACTINY_PATHWAY | 1.05e-05 | 10 | 64 | 3 | MM1528 | |
| Pathway | BIOCARTA_ACTINY_PATHWAY | 1.91e-05 | 12 | 64 | 3 | M7825 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COPII_VESICLE_FORMATION | 1.91e-05 | 12 | 64 | 3 | M47770 | |
| Pubmed | NCOA2 CYLD BCL9L NCOA3 TCF7 ATN1 ATXN7L1 SOBP SEC24A NACA GATA1 TNRC6B PUM2 BCL9 TAB3 NCOR1 SMARCC2 PAX7 CNOT2 FOXK1 | 2.19e-09 | 1429 | 97 | 20 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA2 BCL9L NCOA3 ATN1 SOBP BCL9 NCOR1 TNRC18 TPRX1 SMARCC2 FOXK1 | 4.34e-09 | 351 | 97 | 11 | 38297188 |
| Pubmed | NCOA2 BCL9L NCOA3 ATN1 FOSL2 BCL9 NCOR1 TNRC18 SMARCC2 FOXK1 | 4.36e-09 | 268 | 97 | 10 | 33640491 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA2 BCL9L NCOA3 ATN1 SEC24A TNRC6B PUM2 BCL9 NCOR1 NUP155 CNOT2 FOXK1 | 5.97e-09 | 457 | 97 | 12 | 32344865 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 SH3RF1 PPRC1 FOSL2 ICE1 BCL9 MAST2 DENND1A ITGB4 SCAF1 NCOR1 TNRC18 ZNF296 KCNH2 AGRN FOXK1 AGAP3 | 1.05e-08 | 1105 | 97 | 17 | 35748872 |
| Pubmed | 1.15e-08 | 152 | 97 | 8 | 38360978 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CYLD SH3RF1 SEC24A IQSEC2 MAST2 DENND1A TAB3 STIM1 SLC12A2 MAP2K7 MEX3B FOXK1 GAB1 OTOG AGAP3 | 1.67e-08 | 861 | 97 | 15 | 36931259 |
| Pubmed | 2.09e-07 | 5 | 97 | 3 | 10803578 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 3.63e-07 | 430 | 97 | 10 | 35044719 | |
| Pubmed | 4.18e-07 | 6 | 97 | 3 | 16373399 | ||
| Pubmed | NCOA2 CYLD NCOA3 PRR36 IQSEC2 TNRC6B BCL9 KHSRP NCOR1 SEC24C ABI2 SMARCC2 WASF1 AGRN | 4.70e-07 | 963 | 97 | 14 | 28671696 | |
| Pubmed | CYLD BCL9L IQSEC2 NACA TNRC6B TAB3 KHSRP STIM1 TNRC18 ABI2 SMARCC2 LNPK WASF1 CNOT2 AGAP3 | 6.13e-07 | 1139 | 97 | 15 | 36417873 | |
| Pubmed | CCHCR1 ATN1 TNRC6B TNS2 ITGB4 SCAF1 NCOR1 PTPRN SMARCC2 AGRN ALG13 | 1.09e-06 | 608 | 97 | 11 | 16713569 | |
| Pubmed | CYLD SEC24A TNRC6B DHX9 STIM1 NCOR1 SLC12A2 NUP155 SEC24C WASF1 GAB1 AGAP3 | 1.79e-06 | 777 | 97 | 12 | 35844135 | |
| Pubmed | 2.49e-06 | 10 | 97 | 3 | 15001550 | ||
| Pubmed | 3.09e-06 | 425 | 97 | 9 | 24999758 | ||
| Pubmed | SH3RF1 IQSEC2 COL22A1 MAST2 DSCAML1 STIM1 NCOR1 TNRC18 TRIM50 FOXK1 OTOG | 3.62e-06 | 689 | 97 | 11 | 36543142 | |
| Pubmed | 3.72e-06 | 83 | 97 | 5 | 28794006 | ||
| Pubmed | NCOA2 TCF7 SH3RF1 FOXN4 FOSL2 GATA1 OSR2 ONECUT1 PAX7 CNOT2 FOXK1 | 4.75e-06 | 709 | 97 | 11 | 22988430 | |
| Pubmed | Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis. | 7.70e-06 | 2 | 97 | 2 | 21220509 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 30273195 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 38811552 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 15371335 | ||
| Pubmed | A novel SRC-2-dependent regulation of epithelial-mesenchymal transition in breast cancer cells. | 7.70e-06 | 2 | 97 | 2 | 30048685 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 38461287 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 20682801 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 33767438 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 12089344 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 16190876 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26040939 | ||
| Pubmed | The Association Between WAVE1 and -3 and the ARP2/3 Complex in PC 3 Cells. | 7.70e-06 | 2 | 97 | 2 | 26977009 | |
| Pubmed | 1.15e-05 | 16 | 97 | 3 | 22792322 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.18e-05 | 180 | 97 | 6 | 35198878 | |
| Pubmed | 1.39e-05 | 17 | 97 | 3 | 19183483 | ||
| Pubmed | NCOA2 NCOA3 TCF7 FOSL2 GATA1 ONECUT1 NCOR1 PER3 ZNF296 CNOT2 FOXK1 | 1.61e-05 | 808 | 97 | 11 | 20412781 | |
| Pubmed | BCL9L FOSL2 NACA TNRC6B PUM2 ICE1 DENND1A SCAF1 SLC12A2 ABI2 FBXO28 AGRN CNOT2 FOXK1 AGAP3 | 1.68e-05 | 1497 | 97 | 15 | 31527615 | |
| Pubmed | 1.89e-05 | 533 | 97 | 9 | 25544563 | ||
| Pubmed | 1.91e-05 | 407 | 97 | 8 | 12693553 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 21035760 | ||
| Pubmed | Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors. | 2.31e-05 | 3 | 97 | 2 | 24550004 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 21059860 | ||
| Pubmed | Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. | 2.31e-05 | 3 | 97 | 2 | 22101766 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 21735116 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 34545187 | ||
| Pubmed | Genomic organization and expression profile of the human and mouse WAVE gene family. | 2.31e-05 | 3 | 97 | 2 | 12856283 | |
| Pubmed | Absence of the steroid receptor coactivator-3 induces B-cell lymphoma. | 2.31e-05 | 3 | 97 | 2 | 16675958 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 33649334 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 15698540 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 9506940 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 28390937 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 19277704 | ||
| Pubmed | Research resource: loss of the steroid receptor coactivators confers neurobehavioral consequences. | 2.31e-05 | 3 | 97 | 2 | 23927929 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 19052561 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 9732292 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 15280206 | ||
| Pubmed | HUNK inhibits cargo uptake and lysosomal traffic in the caveolar pathway via the AGAP3/ARF6. | 2.31e-05 | 3 | 97 | 2 | 38071109 | |
| Pubmed | Characterization of the WAVE1 knock-out mouse: implications for CNS development. | 2.31e-05 | 3 | 97 | 2 | 12716942 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 18845648 | ||
| Pubmed | The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. | 2.31e-05 | 3 | 97 | 2 | 12138202 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 11923473 | ||
| Pubmed | Structure and chromosomal locations of mouse steroid receptor coactivator gene family. | 2.31e-05 | 3 | 97 | 2 | 10501088 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 20637214 | ||
| Pubmed | Expression and subcellular localization of WAVE isoforms in the megakaryocyte/platelet lineage. | 2.31e-05 | 3 | 97 | 2 | 15670045 | |
| Pubmed | The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism. | 2.31e-05 | 3 | 97 | 2 | 16423883 | |
| Pubmed | 2.32e-05 | 20 | 97 | 3 | 11877444 | ||
| Pubmed | 2.70e-05 | 21 | 97 | 3 | 19596656 | ||
| Pubmed | 3.30e-05 | 130 | 97 | 5 | 12421765 | ||
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 3.48e-05 | 218 | 97 | 6 | 33378226 | |
| Pubmed | 3.58e-05 | 23 | 97 | 3 | 19737349 | ||
| Pubmed | DTNB SEC24A TNS2 TAB3 STIM1 NCOR1 SLC12A2 NUP155 PTPRN ABI2 WASF1 GAB1 | 3.60e-05 | 1049 | 97 | 12 | 27880917 | |
| Pubmed | 3.67e-05 | 446 | 97 | 8 | 24255178 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 26066330 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 15143189 | ||
| Pubmed | Neutrophils establish rapid and robust WAVE complex polarity in an actin-dependent fashion. | 4.60e-05 | 4 | 97 | 2 | 19200726 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 18267973 | ||
| Pubmed | Selective recruitment of p160 coactivators on glucocorticoid-regulated promoters in Schwann cells. | 4.60e-05 | 4 | 97 | 2 | 15331759 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 10598588 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 17664349 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 19699733 | ||
| Pubmed | The role of the C-terminal domain of PCSK9 and SEC24 isoforms in PCSK9 secretion. | 4.60e-05 | 4 | 97 | 2 | 32058034 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 19462000 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 15951562 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 19095746 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 12893883 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 19198856 | ||
| Pubmed | Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy. | 4.60e-05 | 4 | 97 | 2 | 22560224 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 27605705 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 11851396 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 26267537 | ||
| Pubmed | Nuclear receptor coregulator SNP discovery and impact on breast cancer risk. | 4.60e-05 | 4 | 97 | 2 | 20003447 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 10404183 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 15563469 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 15563453 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 6.19e-05 | 774 | 97 | 10 | 15302935 | |
| Pubmed | CYLD ATN1 ATXN7L1 TNRC6B C16orf96 MAST2 SCAF1 SMARCC2 MAP2K7 FOXK1 AGAP3 ALG13 | 6.52e-05 | 1116 | 97 | 12 | 31753913 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NCOA2 ATXN7L1 SOBP DTNB FOSL2 WASF3 FRMPD1 TNRC6B DENND1A ADCY1 TNRC18 MAST1 C1orf159 AGAP3 | 6.58e-05 | 1489 | 97 | 14 | 28611215 |
| Pubmed | 6.92e-05 | 78 | 97 | 4 | 28611094 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 10652338 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 17950690 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 17476305 | ||
| Interaction | YWHAH interactions | NCOA2 CYLD NCOA3 EPPK1 SH3RF1 SEC24A IQSEC2 TNS2 MAST2 DENND1A TAB3 STIM1 SLC12A2 ABI2 KCNH2 MAST1 WASF1 MEX3B FOXK1 GAB1 OTOG AGAP3 | 7.64e-09 | 1102 | 96 | 22 | int:YWHAH |
| Interaction | TLE3 interactions | NCOA2 BCL9L NCOA3 ATN1 SEC24A GATA1 OSR2 BCL9 NCOR1 TNRC18 SMARCC2 PAX7 ALG13 | 2.69e-08 | 376 | 96 | 13 | int:TLE3 |
| Interaction | YWHAE interactions | CYLD SH3RF1 SEC24A IQSEC2 WASF3 TNS2 MAST2 DENND1A TAB3 DHX9 STIM1 ABI2 KCNH2 MAST1 SMARCC2 WASF1 AGRN MEX3B FOXK1 GAB1 OTOG AGAP3 | 7.90e-08 | 1256 | 96 | 22 | int:YWHAE |
| Interaction | BCL9 interactions | 1.76e-07 | 86 | 96 | 7 | int:BCL9 | |
| Interaction | ALG13 interactions | 2.27e-07 | 183 | 96 | 9 | int:ALG13 | |
| Interaction | YWHAB interactions | CYLD SH3RF1 SEC24A IQSEC2 WASF3 TNS2 MAST2 DENND1A ITGB4 DHX9 STIM1 ABI2 MAST1 WASF1 MEX3B FOXK1 GAB1 OTOG AGAP3 | 2.57e-07 | 1014 | 96 | 19 | int:YWHAB |
| Interaction | NUP35 interactions | NCOA2 BCL9L NCOA3 ATN1 SEC24A TNRC6B PUM2 BCL9 NCOR1 NUP155 CNOT2 FOXK1 | 8.17e-07 | 424 | 96 | 12 | int:NUP35 |
| Interaction | TOP3B interactions | EPPK1 SH3RF1 PPRC1 SEC24A FOSL2 TNRC6B ICE1 BCL9 MAST2 DENND1A ITGB4 DHX9 SCAF1 NCOR1 TNRC18 ZNF296 KCNH2 AGRN MEX3B CNOT2 FOXK1 AGAP3 | 1.17e-06 | 1470 | 96 | 22 | int:TOP3B |
| Interaction | FMR1 interactions | NCOA2 CYLD NCOA3 IQSEC2 TNRC6B PUM2 BCL9 KHSRP DHX9 NCOR1 SMARCC2 MEX3B ALG13 | 1.55e-06 | 536 | 96 | 13 | int:FMR1 |
| Interaction | EYA4 interactions | 2.42e-06 | 243 | 96 | 9 | int:EYA4 | |
| Interaction | PAX9 interactions | 2.92e-06 | 130 | 96 | 7 | int:PAX9 | |
| Interaction | CRX interactions | 3.48e-06 | 254 | 96 | 9 | int:CRX | |
| Interaction | SNTB2 interactions | 5.50e-06 | 143 | 96 | 7 | int:SNTB2 | |
| Interaction | SEC16A interactions | SEC24A TNRC6B TIPARP STIM1 NUP155 SEC24C LNPK MAP2K7 MEX3B CNOT2 ALG13 | 5.82e-06 | 426 | 96 | 11 | int:SEC16A |
| Interaction | TNRC6B interactions | 8.11e-06 | 282 | 96 | 9 | int:TNRC6B | |
| Interaction | SEC24A interactions | 1.18e-05 | 224 | 96 | 8 | int:SEC24A | |
| Interaction | YWHAZ interactions | CYLD SH3RF1 SEC24A IQSEC2 WASF3 SH2D3C MAST2 DENND1A TAB3 STIM1 NCOR1 EFNB3 ABI2 MAST1 WASF1 MEX3B FOXK1 GAB1 OTOG | 1.24e-05 | 1319 | 96 | 19 | int:YWHAZ |
| Interaction | TBR1 interactions | 1.67e-05 | 113 | 96 | 6 | int:TBR1 | |
| Interaction | EGR2 interactions | 1.77e-05 | 171 | 96 | 7 | int:EGR2 | |
| Interaction | TBXT interactions | 1.94e-05 | 116 | 96 | 6 | int:TBXT | |
| Interaction | MXRA7 interactions | 2.24e-05 | 71 | 96 | 5 | int:MXRA7 | |
| Interaction | NCOR2 interactions | 3.82e-05 | 264 | 96 | 8 | int:NCOR2 | |
| Interaction | TEKT3 interactions | 3.87e-05 | 40 | 96 | 4 | int:TEKT3 | |
| Interaction | SRA1 interactions | 4.78e-05 | 83 | 96 | 5 | int:SRA1 | |
| Interaction | TRIP6 interactions | 5.31e-05 | 358 | 96 | 9 | int:TRIP6 | |
| Interaction | TNRC6A interactions | 5.79e-05 | 280 | 96 | 8 | int:TNRC6A | |
| Interaction | NCOR1 interactions | 5.91e-05 | 363 | 96 | 9 | int:NCOR1 | |
| Interaction | GSC interactions | 5.99e-05 | 87 | 96 | 5 | int:GSC | |
| Interaction | DCAF7 interactions | 6.56e-05 | 368 | 96 | 9 | int:DCAF7 | |
| Interaction | AR interactions | NCOA2 BCL9L NCOA3 EPPK1 ATN1 FOSL2 SH2D3C BCL9 TIPARP KHSRP DHX9 NCOR1 TNRC18 SMARCC2 FOXK1 | 6.75e-05 | 992 | 96 | 15 | int:AR |
| Interaction | PRAM1 interactions | 6.77e-05 | 46 | 96 | 4 | int:PRAM1 | |
| Interaction | SMARCE1 interactions | 6.88e-05 | 287 | 96 | 8 | int:SMARCE1 | |
| Interaction | ZNF609 interactions | 7.07e-05 | 146 | 96 | 6 | int:ZNF609 | |
| Interaction | YWHAG interactions | CYLD SH3RF1 SEC24A DZIP1L IQSEC2 SH2D3C TNS2 MAST2 DENND1A TAB3 STIM1 WASF1 MEX3B FOXK1 GAB1 OTOG AGAP3 | 7.67e-05 | 1248 | 96 | 17 | int:YWHAG |
| Interaction | JUN interactions | 8.14e-05 | 470 | 96 | 10 | int:JUN | |
| Interaction | MAGED1 interactions | 8.34e-05 | 295 | 96 | 8 | int:MAGED1 | |
| Interaction | FGFR1OP2 interactions | 8.67e-05 | 94 | 96 | 5 | int:FGFR1OP2 | |
| Interaction | FUBP3 interactions | 8.74e-05 | 297 | 96 | 8 | int:FUBP3 | |
| Interaction | NCOA3 interactions | 9.84e-05 | 224 | 96 | 7 | int:NCOA3 | |
| Interaction | UPF1 interactions | CYLD ATXN7L1 SEC24A TIPARP DHX9 STIM1 SEC24C MEX3B CNOT2 AGAP3 ALG13 | 1.00e-04 | 581 | 96 | 11 | int:UPF1 |
| Interaction | SP7 interactions | 1.03e-04 | 304 | 96 | 8 | int:SP7 | |
| Interaction | SS18L1 interactions | 1.06e-04 | 98 | 96 | 5 | int:SS18L1 | |
| Interaction | LHX8 interactions | 1.18e-04 | 53 | 96 | 4 | int:LHX8 | |
| Interaction | FOS interactions | 1.23e-04 | 312 | 96 | 8 | int:FOS | |
| Interaction | YTHDF2 interactions | 1.23e-04 | 312 | 96 | 8 | int:YTHDF2 | |
| Interaction | FBRS interactions | 1.28e-04 | 102 | 96 | 5 | int:FBRS | |
| Interaction | RNF214 interactions | 1.40e-04 | 104 | 96 | 5 | int:RNF214 | |
| Interaction | SMG7 interactions | 1.43e-04 | 319 | 96 | 8 | int:SMG7 | |
| Interaction | LHX4 interactions | 1.43e-04 | 166 | 96 | 6 | int:LHX4 | |
| Interaction | GARRE1 interactions | 1.48e-04 | 167 | 96 | 6 | int:GARRE1 | |
| Interaction | SEC24B interactions | 1.51e-04 | 240 | 96 | 7 | int:SEC24B | |
| Interaction | SAR1A interactions | 1.63e-04 | 325 | 96 | 8 | int:SAR1A | |
| Interaction | DTX2 interactions | 1.80e-04 | 330 | 96 | 8 | int:DTX2 | |
| Interaction | TLX1 interactions | 1.91e-04 | 175 | 96 | 6 | int:TLX1 | |
| Interaction | USP24 interactions | 1.98e-04 | 112 | 96 | 5 | int:USP24 | |
| Interaction | ARID1B interactions | 2.03e-04 | 177 | 96 | 6 | int:ARID1B | |
| Interaction | CNOT2 interactions | 2.10e-04 | 178 | 96 | 6 | int:CNOT2 | |
| Interaction | WASL interactions | 2.43e-04 | 117 | 96 | 5 | int:WASL | |
| Interaction | ZNF688 interactions | 2.53e-04 | 118 | 96 | 5 | int:ZNF688 | |
| Interaction | SSBP3 interactions | 2.63e-04 | 119 | 96 | 5 | int:SSBP3 | |
| Interaction | NFIA interactions | 2.81e-04 | 188 | 96 | 6 | int:NFIA | |
| Interaction | KRT31 interactions | 3.12e-04 | 453 | 96 | 9 | int:KRT31 | |
| Interaction | GCM1 interactions | 3.12e-04 | 68 | 96 | 4 | int:GCM1 | |
| Interaction | MYOD1 interactions | 3.33e-04 | 194 | 96 | 6 | int:MYOD1 | |
| Interaction | SPAG5 interactions | 3.42e-04 | 195 | 96 | 6 | int:SPAG5 | |
| Interaction | SLA interactions | 3.50e-04 | 29 | 96 | 3 | int:SLA | |
| Interaction | FHL3 interactions | 3.53e-04 | 276 | 96 | 7 | int:FHL3 | |
| Interaction | PRNP interactions | CYLD SH3RF1 IQSEC2 COL22A1 MAST2 DSCAML1 KHSRP STIM1 NCOR1 TNRC18 SLC12A2 TRIM50 FOXK1 OTOG AGAP3 | 3.66e-04 | 1158 | 96 | 15 | int:PRNP |
| Interaction | FAM193A interactions | 3.68e-04 | 71 | 96 | 4 | int:FAM193A | |
| Interaction | R3HDM2 interactions | 3.81e-04 | 129 | 96 | 5 | int:R3HDM2 | |
| Interaction | ARF1 interactions | 4.02e-04 | 282 | 96 | 7 | int:ARF1 | |
| Interaction | KRT27 interactions | 4.13e-04 | 202 | 96 | 6 | int:KRT27 | |
| Interaction | CSDE1 interactions | 4.19e-04 | 284 | 96 | 7 | int:CSDE1 | |
| Interaction | RABGEF1 interactions | 4.35e-04 | 204 | 96 | 6 | int:RABGEF1 | |
| Interaction | NUP155 interactions | 4.53e-04 | 477 | 96 | 9 | int:NUP155 | |
| Interaction | PLSCR4 interactions | 4.54e-04 | 75 | 96 | 4 | int:PLSCR4 | |
| Interaction | SCGN interactions | 4.54e-04 | 75 | 96 | 4 | int:SCGN | |
| Interaction | SSPOP interactions | 4.64e-04 | 7 | 96 | 2 | int:SSPOP | |
| Interaction | PCGF1 interactions | 4.82e-04 | 208 | 96 | 6 | int:PCGF1 | |
| Interaction | ERBB2 interactions | NCOA3 SEC24A SH2D3C TNS2 ITGB4 STIM1 NCOR1 SELENOK NUP155 GAB1 | 4.98e-04 | 589 | 96 | 10 | int:ERBB2 |
| Interaction | TNRC6C interactions | 5.19e-04 | 138 | 96 | 5 | int:TNRC6C | |
| Interaction | PRRC2A interactions | 5.42e-04 | 389 | 96 | 8 | int:PRRC2A | |
| Interaction | PUM2 interactions | 6.30e-04 | 144 | 96 | 5 | int:PUM2 | |
| Interaction | GPS2 interactions | 6.30e-04 | 144 | 96 | 5 | int:GPS2 | |
| Interaction | SOX7 interactions | 6.36e-04 | 82 | 96 | 4 | int:SOX7 | |
| Interaction | TMEM214 interactions | 6.71e-04 | 146 | 96 | 5 | int:TMEM214 | |
| Interaction | EFS interactions | 7.24e-04 | 37 | 96 | 3 | int:EFS | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 8.37e-05 | 25 | 62 | 3 | 775 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 1.35e-03 | 16 | 62 | 2 | 14 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 1.52e-03 | 17 | 62 | 2 | 1291 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.52e-03 | 17 | 62 | 2 | 486 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_CCNE1 | 1.87e-05 | 43 | 96 | 4 | M11048 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_CCNE1 | 2.24e-05 | 45 | 96 | 4 | MM1107 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_UP | 2.49e-05 | 157 | 96 | 6 | M7731 | |
| Coexpression | KAYO_AGING_MUSCLE_UP | 3.11e-05 | 242 | 96 | 7 | M16050 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-07 | 172 | 97 | 7 | 84d16cd7f618c94888920680bdc9e7130d73fd75 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.07e-05 | 152 | 97 | 5 | 854c841c1fc6300b7e9be9c98cbf9b0ce2678690 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.81e-05 | 162 | 97 | 5 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 163 | 97 | 5 | 4af92b211d12c5b88b65bb746242cd702b545bd0 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 163 | 97 | 5 | d24774e0aa612322c22fdb3b314aef275fa01d68 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Liver / Manually curated celltypes from each tissue | 3.15e-05 | 166 | 97 | 5 | 9afa33b5ad27dc33576be592f9b22d8161366838 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-5|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.44e-05 | 169 | 97 | 5 | 9c4e83fe8225d16173a103bf5a57b17d623be923 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.44e-05 | 169 | 97 | 5 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | 390C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.63e-05 | 171 | 97 | 5 | 70963f79711fe6088d6d01b29206b17ab89e5e73 | |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | 4.06e-05 | 175 | 97 | 5 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_Erythro-Mega|lymph-node_spleen / Manually curated celltypes from each tissue | 4.06e-05 | 175 | 97 | 5 | 5ca3369ce2c2bb88ba097260195aecd67cec1a3a | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.52e-05 | 179 | 97 | 5 | 06f92c884189197c86793191c05f65e34925c097 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 4.89e-05 | 182 | 97 | 5 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.02e-05 | 183 | 97 | 5 | 8820cfed27b292bc0bc9cde4005219ed41900552 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 185 | 97 | 5 | 554c5d812197fbf66bf279fcc953277e926ade15 | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 5.28e-05 | 185 | 97 | 5 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | RV-07._Pericyte|RV / Chamber and Cluster_Paper | 5.42e-05 | 186 | 97 | 5 | c533b264fbe12bc35467486fc7fbde24ba968fe1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.42e-05 | 186 | 97 | 5 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | RV-07._Pericyte|World / Chamber and Cluster_Paper | 5.56e-05 | 187 | 97 | 5 | dc274d6bbda619a2c914d84e2b4069cfef1739d1 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.99e-05 | 190 | 97 | 5 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.99e-05 | 190 | 97 | 5 | b5c6f3248c0c2f648e1578457c6a729ca22bf0da | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 6.46e-05 | 193 | 97 | 5 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.11e-05 | 197 | 97 | 5 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.11e-05 | 197 | 97 | 5 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.11e-05 | 197 | 97 | 5 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, condition lineage and cell class | 7.46e-05 | 199 | 97 | 5 | a2be40d367338d32348a6906c8475aa3b544a0f7 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.46e-05 | 199 | 97 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-05 | 200 | 97 | 5 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 1.18e-06 | 189 | 94 | 8 | 5208_DN | |
| Drug | Probenecid [57-66-9]; Down 200; 14uM; PC3; HT_HG-U133A | 1.67e-06 | 198 | 94 | 8 | 4185_DN | |
| Drug | Atovaquone [95233-18-4]; Down 200; 11uM; PC3; HT_HG-U133A | 1.66e-05 | 195 | 94 | 7 | 4201_DN | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.77e-05 | 197 | 94 | 7 | 4761_DN | |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A | 1.77e-05 | 197 | 94 | 7 | 3364_DN | |
| Drug | Isometheptene mucate; Down 200; 8.2uM; HL60; HT_HG-U133A | 1.77e-05 | 197 | 94 | 7 | 3145_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 1.77e-05 | 197 | 94 | 7 | 2766_UP | |
| Drug | Mephenesin [59-47-2]; Up 200; 22uM; HL60; HT_HG-U133A | 1.83e-05 | 198 | 94 | 7 | 2342_UP | |
| Drug | AG-028671 [847803-03-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.83e-05 | 198 | 94 | 7 | 6587_DN | |
| Drug | 7,8-diaminopelargonic acid | 2.40e-05 | 14 | 94 | 3 | CID000000652 | |
| Disease | polycystic ovary syndrome (implicated_via_orthology) | 1.53e-04 | 6 | 95 | 2 | DOID:11612 (implicated_via_orthology) | |
| Disease | Psychotic Disorders | 3.24e-04 | 101 | 95 | 4 | C0033975 | |
| Disease | C-C motif chemokine 25 measurement | 3.64e-04 | 9 | 95 | 2 | EFO_0008050 | |
| Disease | Small cell carcinoma of lung | 7.12e-04 | 54 | 95 | 3 | C0149925 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 7.82e-04 | 13 | 95 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 7.82e-04 | 13 | 95 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 7.82e-04 | 13 | 95 | 2 | C0410203 | |
| Disease | Congenital Structural Myopathy | 7.82e-04 | 13 | 95 | 2 | C0752282 | |
| Disease | Myopathy, Centronuclear, 1 | 7.82e-04 | 13 | 95 | 2 | C4551952 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 9.10e-04 | 14 | 95 | 2 | C1834558 | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 9.10e-04 | 14 | 95 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | Tubular Aggregate Myopathy | 9.10e-04 | 14 | 95 | 2 | C0410207 | |
| Disease | Global developmental delay | 9.15e-04 | 133 | 95 | 4 | C0557874 | |
| Disease | Generalized hypotonia | 1.05e-03 | 15 | 95 | 2 | C1858120 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 1.05e-03 | 15 | 95 | 2 | C3645536 | |
| Disease | Congenital Fiber Type Disproportion | 1.52e-03 | 18 | 95 | 2 | C0546264 | |
| Disease | vital capacity | NCOA3 FRMPD1 C16orf96 NCOR1 MYO1F FAM157B FBN3 FOXK1 GAB1 OTOG AGAP3 | 2.08e-03 | 1236 | 95 | 11 | EFO_0004312 |
| Disease | Epilepsy, Cryptogenic | 2.38e-03 | 82 | 95 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 2.38e-03 | 82 | 95 | 3 | C0751111 | |
| Disease | Aura | 2.38e-03 | 82 | 95 | 3 | C0236018 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 3.17e-03 | 26 | 95 | 2 | DOID:234 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLPPGMQHPASGPAE | 511 | Q96P47 | |
| PTLPNHGGPSTMVPA | 746 | Q9NP73 | |
| HAGSKSPTEPMPPRG | 731 | Q9HCU0 | |
| GAQPLPGHLPSPHAM | 321 | P54259 | |
| MAGRSHPGPLRPLLP | 1 | O00468 | |
| MATPGPRDIPLLPGS | 1 | Q9NQ90 | |
| MGPPLGPARLNPHGS | 371 | Q75N90 | |
| RHGSMCRPSPSPVSP | 121 | Q9ULK2 | |
| PPSPPMSGKGTLGRH | 181 | Q9NYB9 | |
| MAGRPPSVGPVLSAP | 661 | Q8HWS3 | |
| GPMPGSGPTKTPSFH | 691 | O60890 | |
| PIGMPLPSQTPGHSL | 621 | Q8TB72 | |
| HGMRRPPPVNPGSVT | 601 | Q7Z3E1 | |
| HLLPGGFPPTGMPTL | 286 | P23759 | |
| PQPLPPSTMHQGGLA | 326 | P23759 | |
| LHGPSSTPPSSGPGM | 596 | Q8IYY4 | |
| SLILPPGPGGTMKRH | 386 | O14526 | |
| LPARTSPMPGHPTAS | 401 | Q16849 | |
| PPAHMGFRSSPKTPP | 491 | Q13480 | |
| LSQLPPSSSHMGGPP | 271 | Q5JU85 | |
| LPPPPRHASTGAMHP | 296 | Q12809 | |
| LSMGLPPSRTPSHPT | 1026 | P56645 | |
| TTIPGAHSGPMRPLP | 6 | C9JC47 | |
| TPPARPRHMLGLPST | 66 | O14733 | |
| PTSAGMVPINGLPPH | 236 | Q9UBC0 | |
| TTIPGAHSGPMRPLP | 6 | P0CG43 | |
| LPTGDSPLGPMTHRG | 236 | Q9NVS9 | |
| PAMRAPSHKGTPPTP | 121 | Q96S07 | |
| MGSKALPAPIPLHPS | 1 | Q8N2R0 | |
| MLSSQPPPHGDLGAP | 1116 | P16144 | |
| DPHGSSPLASPMSPR | 926 | Q9Y2H9 | |
| GTPSHGIQPPAMSTP | 621 | O75694 | |
| VLSGPVSHLMPFPGP | 371 | P15976 | |
| VSHLMPFPGPLLGSP | 376 | P15976 | |
| TTIPGAHSGPMRPLP | 6 | P0CG42 | |
| PMPGVSVRAGLPPHS | 1091 | Q08828 | |
| MFPAGPPSHSLLRLP | 1 | Q96AY3 | |
| PPMSSPHPGSLPSSF | 351 | Q9Y2F5 | |
| PPRPPASMALLGSQH | 6 | Q8IZ08 | |
| PGPMLHRALSLDPGG | 51 | Q8IVS8 | |
| ASGPHLTMPARPPSL | 1081 | A6NNT2 | |
| PSTEPPRAGGPHTKM | 2006 | Q8TD84 | |
| HPMAPLTSPPSAGSP | 1361 | Q5SYB0 | |
| DIPLGTAPSMPGHNP | 1301 | O00512 | |
| RLMGSPPVPGPSAAL | 231 | Q9NVF7 | |
| PGLPSGSMSPLHTPL | 601 | P57058 | |
| RLSHMPLPPASNPPG | 886 | Q86UU0 | |
| SPHTSPTHGGGRPMP | 531 | O60941 | |
| PTHGGGRPMPMPVRS | 536 | O60941 | |
| PGLASVPGHMALPRP | 86 | P15408 | |
| SAPASPTHPGLMSPR | 416 | P85037 | |
| PTHPGLMSPRSGGLQ | 421 | P85037 | |
| MEHAATTGPRPGPPS | 1 | A2IDD5 | |
| MFPPSGSTGLIPPSH | 1 | Q8TD31 | |
| PGTTSLFTPHPRMPG | 851 | Q8NFW1 | |
| ITLGPPRMESPSGPH | 1566 | Q6P0Q8 | |
| MGTHTSPLQPLGPPA | 901 | Q8TEH3 | |
| ESPPLAMPPGNSHGL | 456 | Q9NQC7 | |
| PMNRSSGTPGRPHPG | 126 | Q96HA4 | |
| ATSRGAEGPLPPPSM | 211 | Q15768 | |
| PRLPSMTGPLLPGQS | 221 | P53992 | |
| PLSMAPPLSLGLPGH | 1031 | Q5VV67 | |
| PTTMGGPLPPHLALK | 106 | Q08211 | |
| MGSPASPQPHPLPSA | 1746 | Q6ZRI0 | |
| TSCPRLSPPLHMAPG | 436 | Q6ZN04 | |
| SSQLGPIHPPPRTSM | 131 | Q92945 | |
| TPSPLLHGPAGMAPR | 91 | Q96NZ1 | |
| SPSPLPHPAMGRAPV | 391 | Q96NZ1 | |
| LGHIFMPPSPSTTPP | 316 | Q8N5C8 | |
| VTPSLHSGPAPRMPL | 96 | O95486 | |
| GPTPGTPSPAMARRS | 166 | Q9H6K5 | |
| TNMPPTILVPHPGGT | 1656 | O75376 | |
| TILVPHPGGTSTPPM | 1661 | O75376 | |
| MSGHTLPPLPVPGTN | 1 | P58107 | |
| LNMSSPPHGSPGLAP | 461 | Q9Y6Q9 | |
| PLRPLGPGRMVSHTP | 941 | Q9NQW1 | |
| GPGRMVSHTPAPPAS | 946 | Q9NQW1 | |
| LMELSPSAPPGGSPH | 596 | Q13586 | |
| AESRPTPMGPPPTSH | 516 | Q8TAQ2 | |
| HSLASPQPAPLMPGS | 626 | Q7Z6J0 | |
| LHTPPSPSRGILPMN | 121 | Q9NZN8 | |
| LSPRHRMSPGVAGSP | 486 | Q15596 | |
| RINHLRGPSPPPMAG | 76 | Q9Y6D0 | |
| SVHGPPPPLLSGLAM | 11 | O15417 | |
| PILSPGRMRSPGSLP | 286 | Q8N7U7 | |
| PLPPGLLPEMAHLSG | 446 | Q96MK2 | |
| SMPTAHRGSLAPPRG | 246 | A6NJB7 | |
| LSPHIHPPSTPTMPG | 456 | A7XYQ1 | |
| SHRKPPSSLGMTPAP | 1136 | Q9H7N4 | |
| GSALHPPPSPTGRLM | 236 | A6NE52 | |
| HGPPGRPHMSSPTRD | 301 | Q9BTD3 | |
| MEPRPTAPSSGAPGL | 1 | P55011 | |
| GPPGPGSSLSSSPMH | 406 | Q9UPY6 | |
| SPMGSPHRASPMRTP | 96 | Q9UF83 | |
| PSLMLGSGVPGHPAA | 216 | P36402 | |
| PASPVSPSGPKGSHM | 341 | Q8N5H7 | |
| HPTPSTAPGPHVPLM | 456 | Q92558 | |
| RGSNSLPMVLPPPSG | 461 | Q86XT4 | |
| PPPPPMLSVSSDSGH | 501 | Q63HR2 | |
| PHRMGSPAPLLPGDL | 1811 | Q9UPQ9 | |
| PHHSPGPMPAGAALL | 66 | Q8WUU4 | |
| LPSGTPPGTMVTAPH | 41 | Q6UXF1 | |
| LPRHLGSPATSVPGM | 221 | Q9C0E8 | |
| GSPATSVPGMGLHPP | 226 | Q9C0E8 | |
| PLPLEIMSGGGTHRP | 966 | O00160 | |
| PPAATPSHKGGPAMT | 1371 | E9PAV3 |